Page breadcrumb nav

VAERS Report 2136758

Case Report Section

Détails du rapport Vaer

Âge: 46 ans

Genre: Male

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (MODERNA))

Type : Coronavirus 2019 vaccine

Fabricant: MODERNA

Lot: 216041bs


Date de réception du rapport
2022-02-24
Date à laquelle le formulaire est complèté
Date de vaccination
2022-01-02
Date d’apparition
1
Nombre de jours (date d’apparition – date de vaccination)
1
Description de l’événement indésirable

and decompensation cordis; atrial fibrillation; day after vaccination, tightness complaints; this case was received via the regulatory authority (reference number: nl-lrb-00780829) on 17-feb-2022 and was forwarded to moderna on 17-feb-2022. this regulatory authority case was reported by a physician and describes the occurrence of cardiac failure (and decompensation cordis), atrial fibrillation (atrial fibrillation) and dyspnoea (day after vaccination, tightness complaints) in a 46-year-old male patient who received mrna-1273 (spikevax) (batch no. 216041bs) for covid-19 vaccination. previously administered products included for product used for unknown indication: biontech/pfizer vaccin (comirnaty) covid-19 vaccin pfizer injvlst 0,3ml on 09-jun-2021, biontech/pfizer vaccin (comirnaty) covid-19 vaccin pfizer injvlst 0 and3ml on 14-jul-2021. past adverse reactions to the above products included no adverse event with biontech/pfizer vaccin (comirnaty) covid-19 vaccin pfizer injvlst 0,3ml, biontech/pfizer vaccin (comirnaty) covid-19 vaccin pfizer injvlst 0 and3ml. on 02-jan-2022, the patient received dose of mrna-1273 (spikevax) (unknown route) 1 dosage form. on 03-jan-2022, the patient experienced cardiac failure (and decompensation cordis) (seriousness criterion hospitalization), atrial fibrillation (atrial fibrillation) (seriousness criterion hospitalization) and dyspnoea (day after vaccination, tightness complaints) (seriousness criterion hospitalization). at the time of the report, cardiac failure (and decompensation cordis), atrial fibrillation (atrial fibrillation) and dyspnoea (day after vaccination, tightness complaints) outcome was unknown. for mrna-1273 (spikevax) (unknown), the reporter did not provide any causality assessments. concomitant medication was not reported. treatment medication was not reported. company comment: this regulatory case concerns a 46-year-old male patient, with history of interchange of vaccine products (two doses of biontech/pfizer vaccine), experienced the unexpected serious adr events cardiac failure, atrial fibrillation, and unexpected serious event dyspnoea, one day after a dose of mrna-1273. the patient was hospitalized for the events. at the time of reporting, the outcome of the events was unknown. the benefit-risk relationship of mrna-1273 is not affected by this report. event seriousness assessed as per regulatory authority reporting.; sender's comments: this regulatory case concerns a 46-year-old male patient, with history of interchange of vaccine products (two doses of biontech/pfizer vaccine), experienced the unexpected serious adr events cardiac failure, atrial fibrillation, and unexpected serious event dyspnoea, one day after a dose of mrna-1273. the patient was hospitalized for the events. at the time of reporting, the outcome of the events was unknown. the benefit-risk relationship of mrna-1273 is not affected by this report. event seriousness assessed as per regulatory authority reporting

Données de laboratoire
na
Liste des symptômes
atrial fibrillation cardiac failure dyspnoea
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Unknown
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Oui
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na